started · updated
Mercado Livre notified by Anvisa over prescription drug sales
Anvisa, Brazil's National Health Surveillance Agency, has formally notified Mercado Livre following the company's announcement that it will begin selling prescription medications through its marketplace starting in October.
The agency is seeking clarification on the legality of this operation, specifically requesting documentation regarding the company's sanitary authorization, the identification of a responsible pharmacist, and protocols for the storage, transport, and verification of medical prescriptions. Anvisa noted that current regulations do not explicitly authorize marketplaces to act as intermediaries for the sale of medications.
The move has drawn significant opposition from the Brazilian Association of Pharmacy and Drugstore Chains (Abrafarma), which has requested urgent clarification from Anvisa regarding the sanitary legality of the model. The announcement also triggered market volatility, impacting the stock prices of major pharmacy retailers such as Raia Drogasil and Pague Menos.
Mercado Livre has stated that it is in dialogue with regulatory bodies and maintains that its platform ensures full traceability and compliance with sanitary standards. The company plans to expand its pharmaceutical presence by integrating third-party pharmacies into its ecosystem, aiming to reach 20 partners by the end of the year.
Entities
Abrafarma · Anvisa · Ascoferj · Brazil · Mercado Livre
Claims
What the coverage asserts, and how many sources carry each claim.
- [DISPUTED] Anvisa formally notified Mercado Livre regarding its plan to sell prescription medications via its marketplace. www.estadao.com.br · www.brasilemfolhas.com.br · atarde.com.br · www.dgabc.com.br · www.infomoney.com.br · +3 more
- [○ 1 SOURCE] Mercado Livre plans to include three third-party pharmacies on its platform in October, aiming for 20 by the end of the year. www.estadao.com.br
- [● 7 SOURCES] Anvisa requested data regarding Mercado Livre's regulatory compliance, including technical responsibility and storage rules. www.brasilemfolhas.com.br · atarde.com.br · www.dgabc.com.br · www.infomoney.com.br · inmagazine.ig.com.br · +2 more
- [● 7 SOURCES] There is currently no regulatory provision authorizing marketplaces to act as intermediaries for the sale of medications. www.brasilemfolhas.com.br · atarde.com.br · www.dgabc.com.br · www.infomoney.com.br · inmagazine.ig.com.br · +2 more
- [DISPUTED] Mercado Livre stated it has not yet received any formal notification regarding the inquiry. atarde.com.br · www.dgabc.com.br · www.infomoney.com.br · exame.com
- [● 3 SOURCES] The Brazilian Association of Pharmacy and Drugstore Chains (Abrafarma) requested urgent clarification from Anvisa regarding the legality of the marketplace model. atarde.com.br · www.osul.com.br · exame.com